The first reports of the use of chloramphenicol in human subjects appeared in 1948 (Ley, Smadel and Crocker; Payne, Knaudt and Palacios) and in these patients toxic effects were not observed. In 1950 Volini. Greenspan, Ehrlich, Gonner, Felsenfeld and Schwartz gave chloramphenicol to two patients suffering from typhoid fever and one patient suffering from brucellosis, and they observed a marked fall in the peripheral white cell count, especially affecting the polymorphonuclear leucocytes; the lymphocyte and monocyte counts remained unaffected, and after stopping the drug the white cell count returned to normal. Gill (1950) reported similar changes in the white cell count of two infants aged 4 months and 13 months, and in these patients the haemoglobin level and red cell count remained unaffected. Rich, Ritterhoff and Hoffmann (1950) described the first fatal case of aplastic anaemia in an adult following chloramphenicol therapy, and similar fatal cases in children were reported by Hawkins and Lederer (1952) and Wolman (1952) in this country and by Sturgeon (1952) in America. Osgood (1953) has reviewed the mortality rates for aplastic anaemia in the United States of America and has claimed that they have not increased since chloramphenicol becanm available. In spite of this, some writers (Franklin and Garrod, 1953) feel that a potentially toxic drug such as chloramphenicol should not be used, while others recommend its use only in exceptional circumstances. Hodgkinson (1954) has investigated the incidence of blood dyscrasias associated with chloramphenicol in the British Isles, but he did not give details of the treatment received by these patients except to state that three of them were still being maintained by blood transfusion. It might be helpful to clinicians encountering similar cases to record our experience with the treatment of a patient suffering from hypoplastic anaemia after chloramphenicol.
Case Report A boy aged 6 years was admitted to hospital for investigation of anaemia. He had been well until 17 weeks before admission when he developed acute bronchitis and was treated with chloromycetin palmitate, 2 drachms six-hourly for seven days (total dosage 7 g.). Eight weeks later he developed whooping cough and was again given chloromycetin palmitate, 2 drachms six-hourly for seven days (total dosage 7 g.). Shortly after the drug was discontinued his parents noticed that he was pale. Five weeks later he developed tonsillitis and was treated with oral penicillin. He gave no history of bleeding into the skin or elsewhere, and, apart from increasing pallor and tiredness, there w.ere no abnormal symptoms.
On admission to hospital the temperature, pulse rate and respiration rate were normal and the only abnormal signs were marked pallor and an apical systolic murmur.
A The marrow smears showed a relatively acellular marrow in which there were very few cells in mitosis. There is experimental evidence that in rabbits (Vasile, 4 , 4 1940) and in dogs (Handler and Featherston, 1943) nicotinamide plays a part in the maturation of red blood cells but there is no direct evidence that this substance is essential for normal erythropoiesis in human beings. Nicotinamide, which is the amide of nicotinic acid and has the advantage of not causing vasodilatation, is thought to act as a coenzyme, and lack of this vitamin results in interference with respiration of the immature red cells. Normal red blood cells contain relatively large amounts of nicotinic acid (Bicknell and Prescott, 1946 The clinical findings in a boy of 6 years of age suffering from hypoplastic anaemia after chloramphenicol are reported. The details of treatment are described and it is thought that nicotinamide may have had a beneficial effect on the anaemia.
I am indebted to Dr. B. G. Ockenden for the bone marrow studies and to Professor Norman B. Capon for his advice.
